» Articles » PMID: 40040696

The Role of Efferocytosis in Inflammatory Bowel Disease

Overview
Journal Front Immunol
Date 2025 Mar 5
PMID 40040696
Authors
Affiliations
Soon will be listed here.
Abstract

Efferocytosis is the process by which various phagocytes clear apoptotic cells. In recent years, an increasing body of evidence has emphasized the importance of efferocytosis in maintaining internal homeostasis. Intestinal macrophages play a crucial role in modulating intestinal inflammation and promoting tissue repair. Inflammatory bowel disease (IBD) is a chronic, progressive, and relapsing condition, primarily marked by the presence of ulcers in the digestive tract. The exact mechanisms underlying IBD are not yet fully understood, and current treatment approaches mainly aim at repairing the damaged intestinal mucosa and reducing inflammatory responses to ease symptoms.This article provides new perspectives on IBD treatment and clinical management by examining the expression of macrophage efferocytosis-related molecules, the effects of efferocytosis on IBD development, the various roles of macrophage efferocytosis in IBD, and treatment strategies for IBD that focus on efferocytosis.

References
1.
Truman L, Ford C, Pasikowska M, Pound J, Wilkinson S, Dumitriu I . CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood. 2008; 112(13):5026-36. DOI: 10.1182/blood-2008-06-162404. View

2.
Schilperoort M, Ngai D, Katerelos M, Power D, Tabas I . PFKFB2-mediated glycolysis promotes lactate-driven continual efferocytosis by macrophages. Nat Metab. 2023; 5(3):431-444. PMC: 10050103. DOI: 10.1038/s42255-023-00736-8. View

3.
Zenewicz L, Antov A, Flavell R . CD4 T-cell differentiation and inflammatory bowel disease. Trends Mol Med. 2009; 15(5):199-207. DOI: 10.1016/j.molmed.2009.03.002. View

4.
Neurath M . New targets for mucosal healing and therapy in inflammatory bowel diseases. Mucosal Immunol. 2013; 7(1):6-19. DOI: 10.1038/mi.2013.73. View

5.
Doran A, Yurdagul Jr A, Tabas I . Efferocytosis in health and disease. Nat Rev Immunol. 2019; 20(4):254-267. PMC: 7667664. DOI: 10.1038/s41577-019-0240-6. View